How can the US catch up on biosimilars? – MedCity News

Getty Images

Biosimilars are a growing share of the U.S. pharmaceuticals market. But while there are at least 240 biosimilars in the development pipeline, just nine have achieved FDA approval and only three have reached the market.

What needs to change for more biosimilars to enter the U.S. market?

Read the full story in MedCity News.

Advertisements

Battle over US overtime pay rules leaves many postdocs in limbo – Nature

Mark Peterson/Redux/eyevine

An ongoing fight over overtime pay rules has left many US postdocs in financial limbo. Labour regulations set to take effect on 1 December would have effectively increased wages for many of these researchers, but on 22 November a US federal judge in Texas temporarily blocked the new rules. “The injunction coming down, especially right before the holiday weekend, was really disheartening,” says Colm Atkins, a postdoc at the University of Texas Medical Branch in Galveston.